Medtronic, Inc.

Medtronic Cryocath LP

Timothy A Ebeling

Xusheng Zhang

Paul R Solheim

Michael W Heinks

Jian L Cao

Gerald P Arne

Yanina Grinberg

Saul E Greenhut

Irving J Sanchez

Craig W Dorma

Mark T Marshall

Troy Edward Jackson

Vladimir Pavlovich Nikolski

Lonny V Cabelka

Joel R Lauer

Brian W Schousek

Joseph Ippolito

Paul D Baker

James Vander Heyden

Robert T Sawchuk

Gary P Kivi

Yuanzhen Liu

Trenton Jay Rehberger

Louis Jacob

Bertin Simeon

Alfonso Aranda Hernandez

Robert W Sawchuk

Wing-Choi Ma

Harold M Dyalsingh

James A Vander Heyden

A method and system for feedback control for cryo-mapping and cryoablation are disclosed. According to one aspect, a cryo-mapping and cryoablation control system includes a first control device configured to receive a target parameter value and a measured output parameter and to output an injection pressure target signal based on a first difference between the target parameter value and the measured output parameter. The system also includes a second control device configured to receive the injection pressure target signal and to output a valve control signal, the valve control signal being used to set a position of an injection pressure valve. The first control device is configured to determine a value of the injection pressure target signal to drive the first difference toward zero.

Feedback control system for cryo-mapping and cryoablation

An implantable medical device system capable of sensing cardiac electrical signals includes a sensing circuit, a therapy delivery circuit and a control circuit. The sensing circuit is configured to receive a cardiac electrical signal and sense a cardiac event in response to the signal crossing a cardiac event sensing threshold. The therapy delivery circuit is configured to deliver an electrical stimulation therapy to a patient's heart via the electrodes coupled to the implantable medical device. The control circuit is configured to control the sensing circuit to set a starting value of the cardiac event sensing threshold and hold the starting value constant for a sense delay interval. The control circuit is further configured to detect an arrhythmia based on cardiac events sensed by the sensing circuit and control the therapy delivery circuit to deliver the electrical stimulation therapy in response to detecting the arrhythmia.

Multi-threshold sensing of cardiac electrical signals in an extracardiovascular implantable cardioverter defibrillator

An implantable medical device system is configured to sense cardiac events in response to a cardiac electrical signal crossing a cardiac event sensing threshold. A control circuit is configured to determine a drop time interval based on a heart rate and control a sensing circuit to hold the cardiac event sensing threshold at a threshold value during the drop time interval.

Multi-threshold sensing of cardiac electrical signals in an implantable medical device

A system, method and leak signal discriminator for detection of a leak or mechanical breach in a catheter shaft in the presence of an electrical interferer are disclosed. According to one aspect, a leak signal discriminator having a leak detection circuit is configured to distinguish between a leak signal arising from a leak in a catheter and an interfering signal arising from an electrical interferer. The leak signal discriminator includes circuitry configured to receive from the leak detection circuit a response signal responsive to a test signal the test signal having component signals, each component signal being at a different frequency, and distinguish between a leak and an electrical interferer based at least in part on an evaluation of the response signal.

'Electrical leak detection system' to detect abnormal conduction within a catheter in the presence of electrical interferers

An extra-cardiovascular implantable cardioverter defibrillator (ICD) having a high voltage therapy module is configured to control a high voltage charging circuit to charge a capacitor to a pacing voltage amplitude to deliver charge balanced pacing pulses. The capacitor is chargeable to a shock voltage amplitude that is greater than the pacing voltage amplitude. The ICD is configured to enable switching circuitry of the high voltage therapy module to discharge the capacitor to deliver a first pulse having a first polarity and a leading voltage amplitude corresponding to the pacing voltage amplitude for pacing the patient's heart via a pacing electrode vector selected from extra-cardiovascular electrodes. The high voltage therapy module delivers a second pulse after the first pulse. The second pulse has a second polarity opposite the first polarity and balances the electrical charge delivered during the first pulse.

Charge balanced cardiac pacing from high voltage circuitry of an extra-cardiovascular implantable cardioverter defibrillator system

A medical electrical lead includes a lead body, a high voltage electrode positioned on the lead body, the high voltage electrode comprising a proximal coated portion, a distal coated portion, and an uncoated portion. Additionally, the medical electrical lead includes a first low voltage electrode and a second low voltage electrode distal to the first low voltage electrode, wherein a first line passes through the first low voltage electrode and the second low voltage electrode, wherein a second line passes through the first low voltage electrode and the uncoated portion, the second line forming a first angle with the first line, and wherein a third line passes through the second low voltage electrode and the uncoated portion, the third line forming a second angle with the first line.

Electrode arrangement for a curvilinear medical device lead

An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.

Anti-tachycardia pacing control in an implantable medical device system

This disclosure is directed to a curvilinear medical electrical lead. For example, a medical electrical lead includes a lead body, a high voltage electrode positioned on the lead body, the high voltage electrode comprising a proximal coated portion, a distal coated portion, and an uncoated portion. Additionally, the medical electrical lead includes a first low voltage electrode and a second low voltage electrode distal to the first low voltage electrode, wherein a first line passes through the first low voltage electrode and the second low voltage electrode, wherein a second line passes through the first low voltage electrode and the uncoated portion, the second line forming a first angle with the first line, and wherein a third line passes through the second low voltage electrode and the uncoated portion, the third line forming a second angle with the first line.

Growing community of inventors

Auburn Hills, MI, United States of America

Timothy A Ebeling